 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 07/06/2026 |
$2.30 |
$2.42 |
$2.30 |
$2.32 |
2.22M | | 07/07/2026 |
$2.32 |
$2.44 |
$2.26 |
$2.37 |
4.75M | | 07/08/2026 |
$2.34 |
$2.35 |
$2.22 |
$2.27 |
4.05M | | 07/09/2026 |
$2.28 |
$2.28 |
$2.21 |
$2.25 |
1.47M | | 07/10/2026 |
$2.25 |
$2.25 |
$2.14 |
$2.22 |
2.30M |
 |
| Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Co. pipeline includes INPEFA (sotagliflozin), LX9211, and LX9851. Sotagliflozin is an orally delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other cardiovascular risk factors. LX9211 is an orally delivered small molecule compound that is being developed for the treatment of neuropathic pain. | |
 |

Lexicon Pharmaceuticals (LXRX) has the following price history information. Looking back at LXRX historical stock prices for the last five trading days, on July 06, 2026, LXRX opened at $2.30, traded as high as $2.42 and as low as $2.30, and closed at $2.32. Trading volume was a total of 2.22M shares. On July 07, 2026, LXRX opened at $2.32, traded as high as $2.44 and as low as $2.26, and closed at $2.37. Trading volume was a total of 4.75M shares. On July 08, 2026, LXRX opened at $2.34, traded as high as $2.35 and as low as $2.22, and closed at $2.27. Trading volume was a total of 4.05M shares. On July 09, 2026, LXRX opened at $2.28, traded as high as $2.28 and as low as $2.21, and closed at $2.25. Trading volume was a total of 1.47M shares. On July 10, 2026, LXRX opened at $2.25, traded as high as $2.25 and as low as $2.14, and closed at $2.22. Trading volume was a total of 2.30M shares.
LXRX Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Lexicon Pharmaceuticals shares, starting with a $10,000 purchase of LXRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/13/2016 |
|
| End date: |
07/10/2026 |
|
| Start price/share: |
$14.49 |
|
| End price/share: |
$2.22 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-84.68% |
|
| Average Annual Total Return: |
-17.11% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,531.95 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 07/06/2026 | $2.32 | | 07/07/2026 | $2.37 | | 07/08/2026 | $2.27 | | 07/09/2026 | $2.25 | | 07/10/2026 | $2.22 |
|
 |